Indian Pharma Under Dark Clouds Of US FDA

DG Shah, secretary general, Indian Pharmaceutical Alliance (IPA), talks to NDTV about the spike in observations and warning letters from US FDA to Indian pharma industry. He says that the number of facilities have gone up and hence an increase. The industry has identified the key issues and is talking several measures to resolve this problem. Now he believes it is just a matter of time. He also spoke about the banning of several drugs by the government and said that due process was not followed and there was no transparency.